MQCC confirms microarray reliability
This article was originally published in The Gray Sheet
Executive Summary
First report of the Microarray Quality Control Consortium, published in the Sept. 8 Nature Biotechnology, concludes that under the appropriate circumstances, "microarray data can indeed be reproducible and comparable among different formats and laboratories." The consortium, spearheaded by FDA scientists, assessed the performance of seven microarray platforms in profiling RNA expression. Published reports question the reliability of the tests, which are used to detect the cellular activity of DNA and RNA. FDA's National Center for Toxicological Research will hold a meeting on microarrays in Jefferson, Ark. on Sept. 21...